NCT03341325

Brief Summary

There is practical evidence but no scientific investigations that persons with severe disorders of consciousness can profit from animal-assisted therapy regarding their level of awareness. The aim of this study is to investigate the effect of animal-assisted therapy on brain activity of inpatients at REHAB Basel with severe disorders of consciousness. To do so, the frontal brain activity of 20 the inpatients at REHAB Basel in a minimally conscious state is investigated via near-infrared spectroscopy (NIRS). Moreover, 20 healthy participants are included as control subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 4, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 14, 2017

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2021

Completed
Last Updated

September 24, 2021

Status Verified

April 1, 2021

Enrollment Period

4.4 years

First QC Date

October 4, 2017

Last Update Submit

September 23, 2021

Conditions

Keywords

animal-assisted therapy

Outcome Measures

Primary Outcomes (1)

  • Near-infrared spectroscopy (NIRS): oxygenated hemoglobin (O2HB), deoxygenated hemoglobin (HHB), total hemoglobin (HB) and blood oxygen saturation (O2Sat)

    All parameters are measured in mmol/ml throughout the sessions, measured via NONIN SenSmart

    2 weeks

Secondary Outcomes (1)

  • Galvanic Skin Response

    2 weeks

Other Outcomes (3)

  • Heart rate / heart rate variability

    2 weeks

  • Basel Vegetative State Assessment (BAVESTA)

    2 weeks

  • Behavioral coding in Noldus Observer

    2 weeks

Study Arms (2)

animal-assisted intervention

EXPERIMENTAL

the intervention is a real animal is presented in different forms to the participants

Other: animal-assisted activity

control intervention

ACTIVE COMPARATOR

the control intervention is a stuffed toy animal is presented in different forms to the participants

Other: control activity

Interventions

a live animal (small dog and/or rabbit)

animal-assisted intervention

a stuffed toy animal

control intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Inpatients of REHAB Basel with severe disorder of consciousness: minimal conscious state defined via: Glasgow Coma Scale (GCS) / Coma Recovery Scale-Revised (Koma Remissions Skala, KRS/KRS-S) / BAVESTA Score
  • Minimum Age of 18 years
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • History of acquired brain-injury
  • Minimum age of 18 years

You may not qualify if:

  • Enrolment of the investigator, his/her family members, employees and other dependent persons,
  • medical contraindications for contact with animals as allergy, phobia etc.
  • If the patient's medication changes radically during the time of data collection (only eligible for clinical participants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

REHAB Basel

Basel, 4012, Switzerland

Location

MeSH Terms

Conditions

Consciousness DisordersBrain Injuries

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Karin Hediger, Dr. phil.

    Swiss TPH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2017

First Posted

November 14, 2017

Study Start

February 1, 2017

Primary Completion

June 28, 2021

Study Completion

June 28, 2021

Last Updated

September 24, 2021

Record last verified: 2021-04

Locations